Lessons learned from BRCA1 and BRCA2

被引:131
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [31] The clinical management of BRCA1 and BRCA2 mutation carriers
    Anthony P. Gulati
    Susan M. Domchek
    Current Oncology Reports, 2008, 10 : 47 - 53
  • [32] BRCA1 and BRCA2 mutations and the risk for colorectal cancer
    Sopik, V.
    Phelan, C.
    Cybulski, C.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 87 (05) : 411 - 418
  • [33] Genetic testing for BRCA1 and BRCA2 in the Province of Ontario
    Finch, A.
    Wang, M.
    Fine, A.
    Atri, L.
    Khalouei, S.
    Pupavac, M.
    Rosen, B.
    Eisen, A.
    Elser, C.
    Charames, G.
    Metcalfe, K.
    Chang, M. C.
    Narod, S. A.
    Lerner-Ellis, J.
    CLINICAL GENETICS, 2016, 89 (03) : 304 - 311
  • [34] Clinical significance of large rearrangements in BRCA1 and BRCA2
    Judkins, Thaddeus
    Rosenthal, Eric
    Arnell, Christopher
    Burbidge, Lynn Anne
    Geary, Wade
    Barrus, Toby
    Schoenberger, Jeremy
    Trost, Jeffrey
    Wenstrup, Richard J.
    Roa, Benjamin B.
    CANCER, 2012, 118 (21) : 5210 - 5216
  • [35] Refining BRCA1 and BRCA2 penetrance estimates in the clinic
    Susan M. Domchek
    Current Breast Cancer Reports, 2009, 1 (3) : 127 - 130
  • [36] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261
  • [37] Recurrent mutations of BRCA1 and BRCA2 in Poland: an update
    Szwiec, M.
    Jakubowska, A.
    Gorski, B.
    Huzarski, T.
    Tomiczek-Szwiec, J.
    Gronwald, J.
    Debniak, T.
    Byrski, T.
    Kluzniak, W.
    Wokolorczyk, D.
    Birkenfeld, B.
    Akbari, M. R.
    Narod, S. A.
    Lubinski, J.
    Cybulski, C.
    CLINICAL GENETICS, 2015, 87 (03) : 288 - 292
  • [38] BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
    Steel, CM
    Anderson, E
    Campbell, J
    Cetnarskyj, R
    Drummond, S
    Kunkler, I
    Kurian, R
    Mackay, J
    Mackenzie, M
    Porter, D
    Porteous, M
    Smyth, E
    Steel, M
    Thomas, R
    Warner, J
    Young, I
    Young, D
    Anderson, V
    Beers, C
    Scarborough, BC
    Baty, D
    Goudie, D
    McLeish, L
    Reis, M
    Thompson, A
    Young, D
    Yule, J
    Bell, C
    Brown, I
    Gibbons, B
    Gregory, H
    Haites, N
    Kelly, K
    Milner, B
    Schofield, A
    Smyth, E
    Black, D
    Boyd, M
    Renwick, A
    Black, R
    Brewster, D
    Fordyce, A
    Bradley, A
    Graham, C
    Johnston, W
    Mallon, E
    Morrison, P
    Cooke, S
    Davidson, R
    Douglas, F
    BRITISH JOURNAL OF CANCER, 2003, 88 (08) : 1256 - 1262
  • [39] Highlight: BRCA1 and BRCA2 proteins in breast cancer
    Daniel, DC
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (01) : 68 - 83
  • [40] Clinical management of BRCA1 and BRCA2 mutation carriers
    S M Domchek
    B L Weber
    Oncogene, 2006, 25 : 5825 - 5831